Britain secures 60 million doses of Sanofi/GSK COVID-19 vaccine

18:40 29/07/2020
Britain has signed a deal for up to 60 million doses of a possible COVID-19 vaccine being developed by Sanofi (SASY.PA) and GlaxoSmithKline (GSK.L), it said on Wednesday, its fourth such arrangement as the race to tame the pandemic heats up.
Leave your comment